PMID: 8602171Mar 26, 1996Paper

Role of E. coli DNA helicase II in a umuCD-dependent Wiegle reactivation

Mutation Research
M L Altshuler

Abstract

Wiegle reactivation is a manifestation of a umuCD-mediated enhancement in the replication of damaged phage DNA (Caillet-Fauquet et al., 1977; Defais et al., 1989; Rajagopalan et al., 1992). I have obtained Wiegle reactivation of lambda by irradiating the uvrA cells in rich growth medium. This Wiegle reactivation was lost upon transduction of the umuC mutation into the strain. There was also a drastic reduction of Wiegle reactivation in an isogenic strain carrying the uvrA mutation and deletion of the uvrD gene. (uvrD codes for E. coli DNA helicase II). The effect of the uvrD deletion on Wiegle reactivation can indicate a specific requirement of DNA helicase II for the unwinding of damaged phage DNA during its replication or (and) an inefficient induction of the SOS response in delta uvrD uvrA cells.

References

Feb 1, 1979·Molecular & General Genetics : MGG·R H RothmanA J Clark
Apr 17, 1979·Molecular & General Genetics : MGG·G C Walker, P P Dobson
Nov 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·M RajagopalanH Echols
Sep 1, 1990·Mutation Research·M GrilleyP Modrich
Jul 14, 1989·Science·R S LahueP Modrich
Jan 1, 1983·Molecular & General Genetics : MGG·M Defais
Jul 1, 1953·Proceedings of the National Academy of Sciences of the United States of America·J J Weigle
Jun 1, 1958·Proceedings of the National Academy of Sciences of the United States of America·J N Adams, S E Luria

❮ Previous
Next ❯

Citations

Jan 13, 2000·Molecular Microbiology·C Bruand, S D Ehrlich

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacteriophage: Phage Therapy

Phage therapy uses bacterial viruses (bacteriophages) to treat bacterial infections and is widely being recognized as an alternative to antibiotics. Here is the latest research.